Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Real-world use of chemotherapy for Kaposi’s sarcoma in a large community-based HIV primary care system in Kenya

Fig. 1

Cumulative incidence of chemotherapy initiation after KS diagnosis among HIV-infected patients newly diagnosed with Kaposi’s sarcoma between 2009 and 2012 in a large community-based primary care network in Kenya. Death prior to chemotherapy is accommodated as a competing event. a all patients diagnosed with KS b restricted to KS patients with a chemotherapy indication

Back to article page